Cargando…

S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)

Detalles Bibliográficos
Autores principales:	Kater, Arnon, Harrup, Rosemary, Kipps, Thomas J, Eichhorst, Barbara, Owen, Carolyn J, Assouline, Sarit, Lamanna, Nicole, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Mellink, Clemens, Chyla, Brenda, Thadani-Mulero, Maria, Lefebure, Marcus, Jiang, Yanwen, Millen, Rosemary, Boyer, Michelle, Seymour, John F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428463/ http://dx.doi.org/10.1097/01.HS9.0000967716.49281.3f

Ejemplares similares

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
por: Kater, Arnon P., et al.
Publicado: (2020)

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
por: Seymour, John F., et al.
Publicado: (2022)

Murano
Publicado: (1969)

Murano : Memoranda 73
Publicado: (1975)

The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: post-hoc analyses from the phase III MURANO study
por: Mato, Anthony R., et al.
Publicado: (2020)

Apparatus experiment R-201
por: Albrow, M G, et al.
Publicado: (1971)

Exploring the impact and experience of fractional work in medicine: a qualitative study of medical oncologists in Australia
por: Kirby, Emma, et al.
Publicado: (2019)

Status and intentions exp. R201
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1973)

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
por: Assouline, Sarit, et al.
Publicado: (2012)

Request approval for the proposed change in the apparatus of exp. R201
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1973)

The Cellobiose Sensor CebR Is the Gatekeeper of Streptomyces scabies Pathogenicity
por: Francis, Isolde M., et al.
Publicado: (2015)

A Qualitative Study of Medical Oncologists’ Experiences of Their Profession and Workforce Sustainability
por: Broom, Alex, et al.
Publicado: (2016)

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
por: Thompson, Meghan C., et al.
Publicado: (2022)

Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development
por: Rogalińska, Małgorzata, et al.
Publicado: (2017)

Mapping of the binding site for FcμR in human IgM-Fc
por: Nyamboya, Rosemary A., et al.
Publicado: (2020)

Utilización de la fauna silvestre en el altiplano potosino-zacatecano
por: Mellink, Eric
Publicado: (1986)

Run 138 F, 22.2.1972: Tests on septa magnets for experiments R201 and R602
por: Kantardjian, G
Publicado: (1972)

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy
por: Martin, Mickaël, et al.
Publicado: (2017)

Assessing Road to Mental Readiness (R2MR) training among correctional workers in Canada
por: Johnston, Matthew S., et al.
Publicado: (2023)

Response to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case report
por: Lv, You, et al.
Publicado: (2022)

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
por: Baliakas, Panagiotis, et al.
Publicado: (2022)

CCR2 and coronary artery disease: a woscops substudy
por: Dow, David J, et al.
Publicado: (2010)

Application of the Adaptive Validation Substudy Design to Colorectal Cancer Recurrence
por: Collin, Lindsay J, et al.
Publicado: (2020)

The international ENIGMA-II substudy on postoperative cognitive disorders (ISEP)
por: Haller, Guy, et al.
Publicado: (2021)

Functional imaging in asthma and COPD: design of the NOVELTY ADPro substudy
por: Marshall, Helen, et al.
Publicado: (2023)

Impact of Ezetimibe on New‐Onset Diabetes: A Substudy of IMPROVE‐IT
por: Shah, Nishant P., et al.
Publicado: (2023)

Runs 117, 122 and 122': Tests of septum magnet for experiment R 201
por: Bonaudi, Franco
Publicado: (1971)

miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker
por: Nadaradjane, Arulraj, et al.
Publicado: (2018)

Circulating Levels of miR-574-5p Are Associated with Neurological Outcome after Cardiac Arrest in Women: A Target Temperature Management (TTM) Trial Substudy
por: Boileau, Adeline, et al.
Publicado: (2019)

Elucidation of repeat motifs R1‐ and R2‐related TRIOBP variants in autosomal recessive nonsyndromic hearing loss DFNB28 among indigenous South African individuals
por: Kabahuma, Rosemary Ida, et al.
Publicado: (2022)

miR-19b targets pulmonary endothelial syndecan-1 following hemorrhagic shock
por: Wu, Feng, et al.
Publicado: (2020)

The Activation of Mesenchymal Stem Cells by Glioblastoma Microvesicles Alters Their Exosomal Secretion of miR-100-5p, miR-9-5p and let-7d-5p
por: Garnier, Delphine, et al.
Publicado: (2022)

Guía para obtener un concreto durable (ACI 201.2R-92)
Publicado: (2001)

JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL
por: Haselager, Marco V., et al.
Publicado: (2023)

Tumour necrosis factor α (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α-Rp55 and slL-6R) serum levels in systemic lupus erythematodes
por: Robak, E., et al.
Publicado: (1996)

The many faces of HFPEF: insights from the CMR substudy of DIAMOND-HFPEF
por: Kanagala, Prathap, et al.
Publicado: (2015)

THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters
por: Sadda, SriniVas R., et al.
Publicado: (2019)

Obesity After Kidney Transplantation—Results of a KTx360°Substudy
por: Nöhre, Mariel, et al.
Publicado: (2020)

Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
por: Metzinger, Mark P., et al.
Publicado: (2020)

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)
por: Eichhorst, Barbara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_12rj6a4hal2kma574or4dkjlb8